Use of Hair to Diagnose Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00390377|
Recruitment Status : Unknown
Verified October 2006 by Fermiscan Ltd.
Recruitment status was: Recruiting
First Posted : October 19, 2006
Last Update Posted : October 19, 2006
This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diffraction patterns of human hair can distinguish samples from healthy subjects from those of diseased subjects, specifically those suffering from breast cancer.
The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Procedure: Cutting scalp hair||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||240 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres.|
|Study Start Date :||October 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00390377
|Contact: Peter W French, BSc, MSc, PhDfirstname.lastname@example.org|
|Australia, New South Wales|
|St George Private Hospital||Recruiting|
|Sydney, New South Wales, Australia, 2217|
|Principal Investigator: Ronald Shnier, MBBS, FRACR|
|Principal Investigator:||Ronald Shnier, MBBS, FRACR||Symbion Health|
|Study Director:||Gary Corino, BSc||Fermiscan Ltd|